Treatment with a Zinc Metalloprotease Purified from Bothrops moojeni Snake Venom (BmooMP-Alpha-I) Reduces the Inflammation in an Experimental Model of Dextran Sulfate Sodium-Induced Colitis.

作者: Maraisa Cristina Silva , Helioswilton Sales-Campos , Carlo José Freire Oliveira , Tamires Lopes Silva , Flávia Batista Ferreira França

DOI: 10.1155/2019/5195134

关键词:

摘要: It has been described that the metalloprotease BmooMP-alpha-I purified from Bothrops moojeni snake venom is able to hydrolyze TNF molecule. However, this observation based mainly on in vitro investigation, addition molecular modeling and docking approaches. Considering there no vivo study demonstrate biological effects of enzyme, major aim present work was investigate whether any anti-inflammatory efficacy by setting up a murine experimental design colitis induced dextran sulfate sodium (DSS). For purpose, C57BL/6 mice were divided into six groups, as follows: (i) animals without intestinal inflammation, (ii) inflammation treated with (50 μg/animal/day), (iii) 3% DSS, (iv) DSS enzyme at 50, 25, or 12.5 μg/animal/day dosages intraperitoneal route. Clinical signs observed daily for calculating morbidity scores, cytokine measurements, histological features. We different doses presented remarkable improvement signs, confirmed significant increase intestine length comparison group. Also, difference between groups vehicle, colon these slightly lower than group healthy animals, induction inflammation. The quantification supernatants tissue homogenates showed reduction 38% IFN-gamma levels, when 50 μg compared receiving only. A 39% levels also all treatment BmooMP-alpha-I, 35% amount IL-12p40. Histological examinations revealed preserved architecture goblet cells reduced ulcer area, mice, which typical inflammatory changes architecture, such ulceration, crypt dilation, loss cell depletion, accompanied infiltration. In conclusion, our results suggest clinical scores findings related model could be attributed ability modulate production locally inflamed intestine. These highlight potential role effectiveness therapeutic alternative type immunopathological condition.

参考文章(34)
A. V. Weizman, E. Ahn, R. Thanabalan, W. Leung, K. Croitoru, M. S. Silverberg, A. Hillary Steinhart, G. C. Nguyen, Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease Alimentary Pharmacology & Therapeutics. ,vol. 35, pp. 342- 349 ,(2012) , 10.1111/J.1365-2036.2011.04956.X
C. A. Siegel, Review article: explaining risks of inflammatory bowel disease therapy to patients Alimentary Pharmacology & Therapeutics. ,vol. 33, pp. 23- 32 ,(2011) , 10.1111/J.1365-2036.2010.04489.X
Xiping Li, Yanjiao Xu, Chengliang Zhang, Li Deng, Mujun Chang, Zaoqin Yu, Dong Liu, Protective Effect of Calculus Bovis Sativus on Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice. Evidence-based Complementary and Alternative Medicine. ,vol. 2015, pp. 469506- 469506 ,(2015) , 10.1155/2015/469506
P.K. Akao, C.C.C. Tonoli, M.S. Navarro, A.C.O. Cintra, J.R. Neto, R.K. Arni, M.T. Murakami, Structural studies of BmooMPα-I, a non-hemorrhagic metalloproteinase from Bothrops moojeni venom Toxicon. ,vol. 55, pp. 361- 368 ,(2010) , 10.1016/J.TOXICON.2009.08.013
P.J. Basso, M.T.C. Fonseca, G. Bonfá, V.B.F. Alves, H. Sales-Campos, V. Nardini, C.R.B. Cardoso, Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease. Brazilian Journal of Medical and Biological Research. ,vol. 47, pp. 727- 737 ,(2014) , 10.1590/1414-431X20143932
Francis S. Markland, Stephen Swenson, Snake venom metalloproteinases. Toxicon. ,vol. 62, pp. 3- 18 ,(2013) , 10.1016/J.TOXICON.2012.09.004
Soichi Takeda, Hiroyuki Takeya, Sadaaki Iwanaga, Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM/ADAMTS family proteins. Biochimica et Biophysica Acta. ,vol. 1824, pp. 164- 176 ,(2012) , 10.1016/J.BBAPAP.2011.04.009
H. Sales-Campos, P.J. Basso, V.B.F. Alves, M.T.C. Fonseca, G. Bonfá, V. Nardini, C.R.B. Cardoso, Classical and recent advances in the treatment of inflammatory bowel diseases Brazilian Journal of Medical and Biological Research. ,vol. 48, pp. 96- 107 ,(2015) , 10.1590/1414-431X20143774
Robert J. Hilsden, Marja J. Verhoef, Heidi Rasmussen, Antony Porcino, Jennifer C.C. DeBruyn, Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflammatory Bowel Diseases. ,vol. 17, pp. 655- 662 ,(2011) , 10.1002/IBD.21360
Vassilis Valatas, Michael Vakas, George Kolios, The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. American Journal of Physiology-gastrointestinal and Liver Physiology. ,vol. 305, ,(2013) , 10.1152/AJPGI.00004.2013